See what’s new.
Setting Rivalries Aside, University Startups Come Together to Pitch 50+ Elite Investors at Triangle Venture Day: Therapeutics 2023
The recurring event offers venture capital investors from across the country an exclusive look at therapeutics startups launching from Duke, UNC, NC State University, and the North Carolina Biotechnology Center.
Durham-based Restor3d raises $17 million
restor3d, a Duke spinout from the lab of Prof Ken Gall (MEMS, Pratt), is also a Duke Capital Partners portfolio company.
Aspirion Acquires Infinia ML, an established leader in AI and Machine Learning
Infinia ML is a Duke artificial intelligence start-up spun out of the lab of Professor Lawrence Carin (ECE, Pratt).
Pivotal Commware Raises $102 million Series D Round to Accelerate mmWave Wireless FWA Rollout
Pivotal Commware is a Duke start-up co-founded by Professor David Smith (ECE, Pratt).
NCBiotech Awards $2.75 Million in Grants, Loans in Latest Quarter
Two Duke start-ups received loans & four Duke projects received Translational Research Grants. Recipients hail from across the university!
Clinetic Announces Series A Funding Round Led by Sopris Capital
Clinetic is a medical records Duke start-up founded on technology developed by a team at the Duke Institute for Health Innovation
Newly Identified Lipid in Breast Milk Might Reduce Cerebral Palsy in Infants
Tellus Therapeutics, a neonatal white matter injury therapeutics start-up, was co-founded by Dr. Eric Brenner (Pediatrics, SOM)
Exploring Entrepreneurship and Social Impact as a New Venture Fellow
Recent Duke Fuqua graduate Lily Schoen reflects on her experience, including working as a New Venture Fellow with Duke OTC
How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up
Duke Professor Bruce Donald and his former students are combining computer science, structural biology, and an entrepreneurial spirit to design new drugs at Ten63 Therapeutics.